Larvol Delta - LILACTIMI-76-Study-to-Evaluate-the-effIcacy-and-Safety-of-Abelacimab-in-Highrisk-Patients-With-Atrial-Fibrillation-Who-Have-Been-Deemed-Unsuitable-for-Oral-Anticoagulation

abelacimab (MAA868) - Anthos Therapeutics

http://clinicaltrials.gov/ct2/show/NCT07739888

Aug 1, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next